In this episode, GOLD is joined by Isabel Afonso, General Manager, Novartis Oncology China, who shares insights on the pharmaceutical landscape of the country and the potential of partnerships with multinational corporations, followed by a conversation with Dr Farid Khan, CEO and Founder, PharmaKure, about the vital ongoing need for drug development and the scientific details behind biopharmaceuticals.

If you're interested in learning more about the topic areas discussed in this episode, check out the following content:

Pharma in… China https://www.emg-gold.com/post/pharma-in-china

A big boom in biotech https://www.emg-gold.com/post/a-big-boom-in-biotech

A heyday for mRNA https://www.emg-gold.com/post/a-heyday-for-mrna

The vast galaxy of neurology https://www.emg-gold.com/post/the-vast-galaxy-of-neurology

S02 E07: Pharma in China, untapped markets and drug development